VOR
Vor Biopharma Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -4.0% ·
share flow +30.0% ·
net new positions -4.2%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 46 | +15 | 17.25M | $317.51M | +16 | −1 |
| Q1 2026 | 31 | +7 | 8.52M | $152.06M | +8 | −1 |
| Q4 2025 | 24 | -1 | 5.67M | $74.16M | n/a | −1 |
| Q3 2025 | 11 | +1 | 478.12K | $23.29M | +2 | −1 |
| Q2 2025 | 7 | -2 | 5.57M | $9.03M | n/a | −2 |
| Q1 2025 | 6 | -1 | 1.58M | $1.14M | n/a | −1 |
| Q4 2024 | 7 | 0 | 1.73M | $1.92M | n/a | n/a |
| Q3 2024 | 6 | 0 | 1.74M | $1.22M | +1 | −1 |
| Q2 2024 | 6 | n/a | 1.49M | $1.49M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 2.53M | +968.1% | $33.04M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | The Vanguard Group ✦ (passive) | 770.25K | +632.2% | $10.07M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 3 | BlackRock ✦ (passive) | 465.64K | +1248.5% | $6.09M | 0.0% | ▲ Add | 3 | SEC ↗ ×8 |
| 4 | Citadel Advisors ✦ | 433.89K | +7530.9% | $5.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | UBS Group AG | 292.12K | n/a | $3.82M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 224.53K | +806.7% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 185.81K | +578.3% | $2.43M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 8 | Tudor Investment Corp Et Al | 167.67K | n/a | $2.19M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Ameriprise Financial Inc | 163.06K | n/a | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 145.64K | +822.6% | $1.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Jane Street Group, Llc | 91.81K | n/a | $1.20M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | State Street Global Advisors ✦ (passive) | 91.05K | +905.7% | $1.19M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Northern Trust Corp | 38.95K | n/a | $509,414 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 28.46K | +538.8% | $372,296 | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 15 | Squarepoint Ops LLC | 18.46K | n/a | $241,444 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Susquehanna International Group, Llp | 14.82K | n/a | $193,833 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citigroup Inc | 6.34K | n/a | $82,927 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 2.31K | +1382.0% | $30,241 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 19 | Barclays Plc | 1.40K | n/a | $18,299 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Mirae Asset Global Investments Co.… | 819 | n/a | $10,713 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Bank Of America Corp /De/ | 396 | n/a | $5,179 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 22 | Bnp Paribas Financial Markets | 291 | n/a | $3,806 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Wells Fargo & Company/Mn | 1 | n/a | $13 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Royal Bank Of Canada | 7 | n/a | $0 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Renaissance Technologies | $711,312 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 79 holders, 40.44M shares, $716.36M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
19.9% of class · View original SEC filing ↗